CRVS Archived Articles
Corvus Pharmaceuticals (NASDAQ:CRVS): Pioneering Selective ITK Inhibition for Immunotherapy
Published on March 13, 2025
Corvus Pharmaceuticals (CRVS): A Promising Oncology Powerhouse Emerging on the Clinical Stage
Published on November 02, 2024